Switching from Risperidone to Aripiprazole

Immediate Initiation with Cross-Titration Protocol

• The American College of Psychiatry recommends starting aripiprazole at 5 mg daily while simultaneously reducing risperidone by 50% using a gradual cross-titration protocol over 1-4 weeks, due to aripiprazole's unique D2 partial agonist properties 1
• The switch can start immediately, with no mandatory waiting period, using a gradual cross-tapering method informed by the half-life and receptor profiles of each medication 1

Cross-Titration Protocol

• Start aripiprazole at 5 mg orally once daily and simultaneously reduce risperidone by 50% of the current dose, monitoring intensively for psychotic symptom exacerbation 1
• Increase aripiprazole to 10-15 mg daily based on tolerability and symptom response, and further reduce risperidone to 25% of the original dose 1
• Titrate aripiprazole to a target dose of 10-30 mg daily and discontinue risperidone completely by week 4 1

Critical Monitoring During the Switch

• Assess psychotic symptoms weekly using standardized scales, as up to one-third of patients may experience symptom worsening when switching antipsychotics 2

Critical Warning: Risk of Psychotic Exacerbation

• Use slower cross-titration (closer to 4 weeks than 1 week) if the patient has severe baseline symptoms or history of rapid relapse, to mitigate the risk of psychotic exacerbation 1
• Maintain some risperidone coverage until aripiprazole reaches therapeutic levels, to minimize the risk of symptom worsening 1

Common Pitfalls to Avoid

• Ensure the patient had at least 4 weeks at therapeutic doses with verified adherence before declaring treatment failure and switching to aripiprazole 1, 3

Expected Timeline for Response

• Positive symptom response should be evident by week 4 after completing the switch, and if symptoms worsen or fail to improve by week 4, reassess diagnosis and consider alternative strategies 1, 3